作者：
Aritro,Nath [1]
;
Patrick A,Cosgrove [1]
;
Hoda,Mirsafian [1]
;
Elizabeth L,Christie [2]
;
Lance,Pflieger [3]
;
Benjamin,Copeland [1]
;
Sumana,Majumdar [1]
;
Mihaela C,Cristea [1]
;
Ernest S,Han [1]
;
Stephen J,Lee [4]
;
Edward W,Wang [4]
;
Sian,Fereday [1]
;
Nadia,Traficante [2]
;
Ravi,Salgia [3]
;
Theresa,Werner [2]
;
Adam L,Cohen [3]
;
Philip,Moos [1]
;
Jeffrey T,Chang [5]
;
David D L,Bowtell [5]
;
Andrea H,Bild [6]
作者单位：
Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Monrovia, CA, USA.
[1]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[2]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
[3]
Division of Gynecologic Oncology, Department of Surgery, City of Hope, Duarte, CA, USA.
[4]
Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
[5]
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
[6]
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA.
[7]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. david.bowtell@petermac.org.
[8]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. david.bowtell@petermac.org.
[9]
Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Monrovia, CA, USA. abild@coh.org.
[10]
DOI
10.1038/s41467-021-23171-3
PMID
34031395
发布时间
2023-11-11
换一批
换一批
